The European Association of Neuro-Oncology guidelines have recently proposed discontinuation of the term ‘IDH mutant glioblastoma’, instead calling these ‘astrocytoma grade 4’ (10). This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).